Samsung Biologics makes $1.8 billion all-cash offer for Switzerland's PolyPeptide Group
South Korea’s Samsung Biologics said on Monday that it had made an all-cash bid of 1.46 billion Swiss francs ($1.8 billion) for Switzerland’s PolyPeptide Group.
Source: Cnbc.com
Original source: https://www.cnbc.com/2026/07/20/samsung-biologics-polypeptide-group-deal-switzerland.html